Longitudinal Urine Drug Testing Among Patients Receiving Opioids for Cancer Pain
Unexplained UDT results were captured at varying timepoints throughout PC engagement, supporting the use of baseline and subsequent UDTs to optimize patient safety in cancer symptom management. PC providers should consider continuing to use UDTs as a way to monitor medication adherence throughout PC engagement.
Authors
- Gennaro Di Tosto (ORCID: https://orcid.org/0000-0003-2402-1925)
- Julia L. Agne (ORCID: https://orcid.org/0000-0002-9967-0818)
- Justin Kullgren
- Ann Scheck McAlearney (ORCID: https://orcid.org/0000-0001-9107-5419)
- Maureen Saphire (ORCID: https://orcid.org/0000-0002-9842-6127)
- Darian C. Rostam
- Laura J. Rush (ORCID: https://orcid.org/0000-0003-3859-6885)
- Amanda Gusovsky (ORCID: https://orcid.org/0000-0002-1380-4839)
- Adria Lam
- Sachin S. Kale (ORCID: https://orcid.org/0000-0002-9792-3914)
Institutions
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- The Ohio State University Wexner Medical Center (US)
- Université Bourgogne Franche-Comté (FR)
- The Ohio State University (US)
Publication Details
- Journal
- Journal of Pain and Symptom Management
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1016/j.jpainsymman.2025.02.473
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- National Center for Advancing Translational Sciences